a quinazoline compound sold by Pfizer under doxazosin cardura brand names Cardura® and Carduran® , is an alpha blocker used to treat high blood pressure and benign prostatic hyperplasia.On February 22, 2005, doxazosin cardura US FDA doxazosin cardura a sustained release form of doxazosin, to be marketed as Cardura® XL.It is an alpha blocker used to treat.

release form of doxazosin, to be marketed as Cardura® XL.It is an alpha blocker used to treat high blood pressure and benign prostatic hyperplasia.On February 22, 2005, the US FDA approved a sustained release form of doxazosin, to doxazosin cardura marketed as Cardura® doxazosin cardura doxazosin cardura an alpha blocker used to treat doxazosin cardura blood pressure and benign prostatic hyperplasia.On February 22, 2005, the US FDA approved doxazosin cardura sustained release form of doxazosin, to be marketed doxazosin cardura doxazosin cardura XL.It is an alpha blocker used to treat high blood doxazosin cardura and benign prostatic hyperplasia.On February 22, 2005, the US FDA approved a sustained release form of doxazosin, to be marketed as Cardura® XL.It is an alpha-1 adrenergic receptor blocker which inhibits the binding of norepinephrine to alpha receptors in the autonomic nervous system. The primary doxazosin cardura of this blockage is relaxed vascular smooth muscle tone (vasodilation), which decreases peripheral vascular resistance, leading to decreased blood pressure.[edit] External links.

muscle tone (vasodilation), which decreases peripheral vascular resistance, leading to decreased blood.